Boyar Asset Management Inc. Raises Holdings in CVS Health Corporation $CVS

Boyar Asset Management Inc. increased its position in shares of CVS Health Corporation (NYSE:CVS) by 1.9% in the 2nd quarter, Holdings Channel reports. The firm owned 18,779 shares of the pharmacy operator’s stock after purchasing an additional 345 shares during the period. Boyar Asset Management Inc.’s holdings in CVS Health were worth $1,295,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bell Investment Advisors Inc boosted its stake in CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 248 shares during the last quarter. Roxbury Financial LLC lifted its stake in shares of CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the last quarter. ORG Partners LLC lifted its stake in shares of CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares during the last quarter. Saudi Central Bank acquired a new position in CVS Health during the 1st quarter worth about $34,000. Finally, Livelsberger Financial Advisory acquired a new position in CVS Health during the 2nd quarter worth about $35,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insiders Place Their Bets

In related news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.22% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Jefferies Financial Group upped their price target on CVS Health from $74.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, June 30th. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a report on Saturday, September 27th. Baird R W upgraded CVS Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 14th. Barclays raised their price target on CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Finally, UBS Group upgraded CVS Health from a “neutral” rating to a “buy” rating and raised their price target for the stock from $67.00 to $79.00 in a research note on Monday, August 18th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $78.25.

CVS Health Stock Up 0.1%

CVS opened at $77.51 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The business has a 50 day simple moving average of $70.71 and a 200-day simple moving average of $67.34. The stock has a market capitalization of $98.31 billion, a P/E ratio of 21.65, a P/E/G ratio of 0.85 and a beta of 0.60. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $79.20.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The business had revenue of $98.92 billion during the quarter, compared to analysts’ expectations of $94.87 billion. During the same period last year, the firm earned $1.83 EPS. The company’s quarterly revenue was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.